Argonaute RNA
Bristol · Founded 2015
About Argonaute RNA
Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. RNAi harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein. Argonaute RNA research projects build on existing intellectual property. They show how their proprietary modification of small interfering RNA (siRNA) allows safe and effective ways to silence specific gene expression.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.3M
- Last round: Series Unknown (Jul 2024)
- Website: https://argonauterna.com/
- Phone: +44 (0)117 974 2561
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/argonaute-rna-147320 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.